Vistagen Therapeutics Inc (VTGN)
4.50
+0.09
(+2.04%)
USD |
NASDAQ |
May 03, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap: 121.61M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 121.61M |
May 02, 2024 | 119.18M |
May 01, 2024 | 128.10M |
April 30, 2024 | 130.53M |
April 29, 2024 | 128.91M |
April 26, 2024 | 128.37M |
April 25, 2024 | 127.02M |
April 24, 2024 | 127.56M |
April 23, 2024 | 130.53M |
April 22, 2024 | 129.18M |
April 19, 2024 | 128.64M |
April 18, 2024 | 127.02M |
April 17, 2024 | 126.21M |
April 16, 2024 | 125.67M |
April 15, 2024 | 128.37M |
April 12, 2024 | 132.15M |
April 11, 2024 | 143.37M |
April 10, 2024 | 137.83M |
April 09, 2024 | 145.13M |
April 08, 2024 | 139.72M |
April 05, 2024 | 136.21M |
April 04, 2024 | 142.96M |
April 03, 2024 | 145.40M |
April 02, 2024 | 145.94M |
April 01, 2024 | 145.94M |
Date | Value |
---|---|
March 28, 2024 | 142.69M |
March 27, 2024 | 123.51M |
March 26, 2024 | 117.56M |
March 25, 2024 | 115.67M |
March 22, 2024 | 112.70M |
March 21, 2024 | 113.91M |
March 20, 2024 | 112.70M |
March 19, 2024 | 112.15M |
March 18, 2024 | 109.72M |
March 15, 2024 | 109.45M |
March 14, 2024 | 105.94M |
March 13, 2024 | 113.51M |
March 12, 2024 | 110.53M |
March 11, 2024 | 112.70M |
March 08, 2024 | 113.78M |
March 07, 2024 | 114.45M |
March 06, 2024 | 119.72M |
March 05, 2024 | 121.34M |
March 04, 2024 | 131.07M |
March 01, 2024 | 137.02M |
February 29, 2024 | 138.10M |
February 28, 2024 | 140.80M |
February 27, 2024 | 142.96M |
February 26, 2024 | 136.34M |
February 23, 2024 | 133.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.43M
Minimum
Jun 26 2023
660.66M
Maximum
Jul 01 2021
152.19M
Average
52.43M
Median
Sep 19 2023
Market Cap Benchmarks
Ardelyx Inc | 2.029B |
Axsome Therapeutics Inc | 3.544B |
Vir Biotechnology Inc | 1.403B |
Immuneering Corp | 48.63M |
NovaBay Pharmaceuticals Inc | 2.856M |
Market Cap Related Metrics
PS Ratio | 58.25 |
Price to Book Value | 0.9864 |
Price | 4.50 |
Earnings Yield | -77.98% |